A Brucella ovis antigenic complex bearing poly-ε-caprolactone microparticles confer protection against experimental brucellosis in mice

被引:39
作者
Murillo, M [1 ]
Grilló, MJ
Reñé, J
Marín, CM
Barberán, M
Goñi, MM
Blasco, JM
Irache, JM
Gamazo, C
机构
[1] Univ Navarra, Dept Technol Pharm, Pamplona 31008, Spain
[2] DGA, SIA, Anim Hlth Unit, Zaragoza 50080, Spain
[3] Univ Navarra, Dept Microbiol, Pamplona 31008, Spain
关键词
microparticles; brucellosis; poly-epsilon-caprolactone;
D O I
10.1016/S0264-410X(01)00177-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A hot saline antigenic extract (HS) from Brucella ovis was encapsulated in poly-epsilon -caprolactone microparticles (PEC), and tested as a vaccine against B. ovis and B. abortus infections in mice. Subcutaneous but not oral administration in BALB/c mice of the HS-PEC induced high amounts of IFN-gamma and IL-2 but low quantities of IL-4 suggesting a combined Th1/Th2 cellular immune response. The vaccine administered either subcutaneously or orally protected mice against B. ovis infection. Such protection was similar to that provided by the reference living attenuated B. melitensis Rev. 1 vaccine. By contrast, only the subcutaneous vaccination with HS-PEC was as effective as Rev. 1 in conferring protection against B. abortus infection. The use of free HS or empty PEC microparticles did not produce any protective effect. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:4099 / 4106
页数:8
相关论文
共 38 条
[1]  
ADAMS G, 1998, 3 FOR INT BRUC AC ME
[2]   COMPARATIVE PROTECTION OF MICE AGAINST VIRULENT AND ATTENUATED STRAINS OF BRUCELLA-ABORTUS BY PASSIVE TRANSFER OF IMMUNE T-CELLS OR SERUM [J].
ARAYA, LN ;
WINTER, AJ .
INFECTION AND IMMUNITY, 1990, 58 (01) :254-256
[3]  
Baras B, 2000, J MICROENCAPSUL, V17, P485
[4]   Preparation and characterization of protein-loaded poly(ε-caprolactone) microparticles for oral vaccine delivery [J].
Benoit, MA ;
Baras, B ;
Gillard, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 184 (01) :73-84
[5]   A review of the use of B-melitensis Rev 1 vaccine in adult sheep and goats [J].
Blasco, JM .
PREVENTIVE VETERINARY MEDICINE, 1997, 31 (3-4) :275-283
[6]   BRUCELLA-MELITENSIS REV-1 VACCINE AS A CAUSE OF HUMAN BRUCELLOSIS [J].
BLASCO, JM ;
DIAZ, R .
LANCET, 1993, 342 (8874) :805-805
[7]   EVALUATION OF WHOLE-CELL AND SUBCELLULAR VACCINES AGAINST BRUCELLA-OVIS IN RAMS [J].
BLASCO, JM ;
GAMAZO, C ;
WINTER, AJ ;
DEBAGUES, MPJ ;
MARIN, C ;
BARBERAN, M ;
MORIYON, J ;
ALONSOURMENETA, B ;
DIAZ, R .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1993, 37 (3-4) :257-270
[8]  
BLASCO JM, 1990, ANIMAL BRUCELLOSIS, V8, P9
[9]   Identification of protective outer membrane antigens of Brucella ovis by passive immunization of mice with monoclonal antibodies [J].
Bowden, RA ;
Estein, SM ;
Zygmunt, MS ;
Dubray, G ;
Cloeckaert, A .
MICROBES AND INFECTION, 2000, 2 (05) :481-488
[10]  
DEBAGUES MPJ, 1994, INFECT IMMUN, V62, P632